1. OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers. (May 2017) Authors: Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J.; Deutsch, E.; Tao, Y. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer. (April 2018) Authors: Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J.; Deutsch, E.; Tao, Y. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers. (April 2019) Authors: Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Leijenaar, R.T.H.; Gorphe, P.; Breuskin, I.; Janot, F.; Robert, C.; Lambin, P.; Temam, S.; Scoazec, J.; Deutsch, E.; Tao, Y. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients. (May 2017) Authors: Ou, D.; Garberis, I.; Adam, J.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J.; Deutsch, E.; Tao, Y. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗